Arrieta A et al. |
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506028
|
Nilius AM et al. |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408246
|
Maves RC et al. |
Antimicrobial susceptibility of Brucella melitensis isolates in Peru. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21199926
|
Wondrack L et al. |
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849266
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Hauser C et al. |
In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25547354
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Salman S et al. |
Pharmacokinetic properties of azithromycin in pregnancy. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19858250
|
Nalca Y et al. |
Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16641435
|
Asgrimsson V et al. |
Novel effects of azithromycin on tight junction proteins in human airway epithelia. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16641453
|
Ulrich M et al. |
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304181
|
Chave JP et al. |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324635
|
Derouin F et al. |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324642
|
Vallée E et al. |
Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324644
|
Merchan LM et al. |
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25385115
|
Mertens JC et al. |
Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324645
|
Dubois J et al. |
In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25348534
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Pajukanta R et al. |
In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329617
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Koletar SL et al. |
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582873
|
Nicolau DP et al. |
Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582906
|
Dagan R et al. |
Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602721
|
McGannon CM et al. |
Different classes of antibiotics differentially influence shiga toxin production. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585113
|
Koetsveld J et al. |
Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28674060
|
Clark C et al. |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183253
|
Yamada K et al. |
Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23733468
|
Blandizzi C et al. |
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959610
|
Moon JE et al. |
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723556
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Bogdanovich T et al. |
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723565
|
Kosowska-Shick K et al. |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723567
|
Ng LK et al. |
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183262
|
Matsui H et al. |
Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048953
|
Prunier AL et al. |
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183270
|
Carannante A et al. |
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070110
|
Collins SA et al. |
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27919896
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Zhang Y et al. |
Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855081
|
Waites KB et al. |
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855075
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Galarza PG et al. |
New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20123998
|
Jaruratanasirikul S et al. |
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851625
|
Shimuta K et al. |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23939890
|
Carryn S et al. |
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069960
|
Babl FE et al. |
Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069974
|
D'Ignazio J et al. |
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16189077
|
Tissi L et al. |
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540695
|
Sahm DF et al. |
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11257013
|
Jensen JS et al. |
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24637681
|
Koirala KD et al. |
Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22371897
|
Bielaszewska M et al. |
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22391549
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Erhardt W et al. |
Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media. |
2000 |
Antimicrob. Agents Chemother. |
pmid:11012390
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Andersen SL et al. |
Efficacy of azithromycin as a causal prophylactic agent against murine malaria. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986022
|
Cigana C et al. |
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17210769
|
Pruul H and McDonald PJ |
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317141
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Farrell DJ et al. |
Results from the Solithromycin International Surveillance Program (2014). |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044551
|
Niki Y et al. |
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840560
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Freeman CD et al. |
Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840585
|
Caronzolo D et al. |
Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. |
2006 |
Antimicrob. Agents Chemother. |
pmid:17005805
|
Nagai K et al. |
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796375
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Sugimura M et al. |
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18676884
|
Liu P et al. |
Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21859932
|
Goldstein EJ et al. |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7625795
|
Sjölund-Karlsson M et al. |
Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21690279
|
Ramya TN et al. |
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060533
|
Su XH et al. |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). |
2015 |
Antimicrob. Agents Chemother. |
pmid:26482313
|
Shima K et al. |
Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23478971
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Goodman CD et al. |
Chemobiosynthesis of new antimalarial macrolides. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23208707
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Rakita RM et al. |
Intracellular activity of azithromycin against bacterial enteric pathogens. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7810998
|
Kim MK et al. |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234843
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Imamura Y et al. |
Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15793115
|
Shima K et al. |
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21321137
|
Chinh NT et al. |
Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21730120
|
Ma Q et al. |
A Waterborne Outbreak of Shigella sonnei with Resistance to Azithromycin and Third-Generation Cephalosporins in China in 2015. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28373192
|
Wind CM et al. |
A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28373191
|
Karlowsky JA et al. |
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760850
|
Yamaguchi H et al. |
Chlamydia pneumoniae resists antibiotics in lymphocytes. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760877
|
Kutlin A et al. |
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796350
|
Jacks SS et al. |
In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709351
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Welsh L et al. |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787907
|
Schroeck JL et al. |
Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25870064
|
Waites KB et al. |
In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824220
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Edelstein PH et al. |
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11451675
|
Matzneller P et al. |
Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23357769
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|